<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">4321</id>
  <title>T3D4267</title>
  <common-name>3-Hydroxy-3-methylglutaryl-CoA</common-name>
  <description>3-hydroxy-3-methylglutaryl CoA (HMG-CoA) is formed when Acetyl-CoA condenses with acetoacetyl-CoA in a reaction that is catalyzed by the enzyme HMG-CoA synthase in the mevalonate pathway or mevalonate-dependent (MAD) route, an important cellular metabolic pathway present in virtually all organisms. HMG-CoA reductase (EC 1.1.1.34) inhibitors, more commonly known as statins, are cholesterol-lowering drugs that have been widely used for many years to reduce the incidence of adverse cardiovascular events. HMG-CoA reductase catalyzes the rate-limiting step in the mevalonate pathway and these agents lower cholesterol by inhibiting its synthesis in the liver and in peripheral tissues. Androgen also stimulates lipogenesis in human prostate cancer cells directly by increasing transcription of the fatty acid synthase and HMG-CoA-reductase genes.  (A3362).</description>
  <cas>1553-55-5</cas>
  <pubchem-id>439218</pubchem-id>
  <chemical-formula>C27H44N7O20P3S</chemical-formula>
  <weight nil="true"/>
  <appearance>White powder.</appearance>
  <melting-point></melting-point>
  <boiling-point></boiling-point>
  <density nil="true"/>
  <solubility></solubility>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism>Metabolism of organophosphates occurs principally by oxidation, by hydrolysis via esterases and by reaction with glutathione. Demethylation and glucuronidation may also occur.  Oxidation of organophosphorus pesticides may result in moderately toxic products.  In general, phosphorothioates are not directly toxic but require oxidative metabolism to the proximal toxin.  The glutathione transferase reactions produce products that are, in most cases, of low toxicity. Paraoxonase (PON1) is a key enzyme in the metabolism of organophosphates. PON1 can inactivate some organophosphates through hydrolysis. PON1 hydrolyzes the active metabolites in several organophosphates insecticides as well as, nerve agents such as soman, sarin, and VX. The presence of PON1 polymorphisms causes there to be different enzyme levels and catalytic efficiency of this esterase, which in turn suggests that different individuals may be more susceptible to the toxic effect of organophosphate exposure.</metabolism>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity>Not listed by IARC.</carcinogenicity>
  <use-source>This is an endogenously produced metabolite found in the human body. It is used in metabolic reactions, catabolic reactions or waste generation.</use-source>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2014-08-29T06:10:46Z</created-at>
  <updated-at type="dateTime">2026-04-05T14:25:29Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia>3-hydroxy-3-methylglutaryl-CoA</wikipedia>
  <uniprot-id nil="true"/>
  <kegg-compound-id>C00356</kegg-compound-id>
  <omim-id nil="true"/>
  <chebi-id>15467</chebi-id>
  <biocyc-id>3-HYDROXY-3-METHYL-GLUTARYL-COA</biocyc-id>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id>HMG</pdb-id>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>C[C@](O)(CC(O)=O)CC(=O)SCCNC(=O)CCNC(=O)C(O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N</moldb-smiles>
  <moldb-formula>C27H44N7O20P3S</moldb-formula>
  <moldb-inchi>InChI=1S/C27H44N7O20P3S/c1-26(2,21(40)24(41)30-5-4-15(35)29-6-7-58-17(38)9-27(3,42)8-16(36)37)11-51-57(48,49)54-56(46,47)50-10-14-20(53-55(43,44)45)19(39)25(52-14)34-13-33-18-22(28)31-12-32-23(18)34/h12-14,19-21,25,39-40,42H,4-11H2,1-3H3,(H,29,35)(H,30,41)(H,36,37)(H,46,47)(H,48,49)(H2,28,31,32)(H2,43,44,45)/t14-,19-,20-,21?,25-,27+/m1/s1</moldb-inchi>
  <moldb-inchikey>CABVTRNMFUVUDM-MIGRVSMKSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal">911.659</moldb-average-mass>
  <moldb-mono-mass type="decimal">911.157467109</moldb-mono-mass>
  <origin>Endogenous</origin>
  <state>Solid</state>
  <logp nil="true"/>
  <hmdb-id>HMDB01375</hmdb-id>
  <chembl-id nil="true"/>
  <chemspider-id>388357</chemspider-id>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference>Williamson I P; Rodwell V W  Isolation and purification of 3-hydroxy-3-methylglutaryl-coenzyme A by ion-exchange chromatography.    Journal of lipid research  (1981),  22(1),  184-7.</synthesis-reference>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM003227</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id>NS00074026</susdat-id>
  <iupac nil="true"/>
  <moldb-polar-surface-area>421.1599999999999</moldb-polar-surface-area>
  <moldb-refractivity>193.70200000000008</moldb-refractivity>
  <moldb-polarizability>81.00926506675063</moldb-polarizability>
  <moldb-rotatable-bond-count>24</moldb-rotatable-bond-count>
  <moldb-acceptor-count>20</moldb-acceptor-count>
  <moldb-donor-count>11</moldb-donor-count>
  <moldb-pka-strongest-acidic>0.8250358493029446</moldb-pka-strongest-acidic>
  <moldb-pka-strongest-basic>5.001361103990641</moldb-pka-strongest-basic>
  <moldb-physiological-charge>-5</moldb-physiological-charge>
  <moldb-number-of-rings>3</moldb-number-of-rings>
  <moldb-alogps-logp>-0.53</moldb-alogps-logp>
  <moldb-alogps-logs>-2.35</moldb-alogps-logs>
  <moldb-alogps-solubility>4.10e+00 g/l</moldb-alogps-solubility>
</compound>
